ArticlePLoS neglected tropical diseases2026
Adverse dengue outcomes in patients with chronic kidney disease: A population-based analysis of 5.8 million individuals from Brazil.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDengue fever poses a major public health threat in Brazil, particularly among individuals with comorbid conditions. Chronic kidney disease (CKD) is known to impair immune defenses and may predispose patients to worse infectious outcomes, but its impact on dengue has not been comprehensively evaluated at the national level. This study aimed to assess the association between CKD and adverse clinical outcomes of dengue fever.
methodsWe conducted a population-based analysis using 2024 data from the Brazilian Information System for Notifiable Diseases (SINAN). Patients with a confirmed diagnosis of dengue, based on laboratory or clinical-epidemiological criteria, were included in the study. The cohort was stratified based on their CKD status. Clinical features and outcomes (hospitalization, severe dengue, and death) were compared. Multivariable logistic regression models weighted by inverse probability of treatment weighting (IPTW) were used to estimate adjusted odds ratios (ORs).
resultsAmong 5,837,904 confirmed dengue cases, 30,527 (0.5%) had CKD. Compared to patients without CKD, those with CKD had significantly higher rates of hospitalization (14% vs. 4%), severe dengue (1.6% vs. 0.1%), and death (2.2% vs. 0.1%) (all p < 0.001). In adjusted analyses, CKD was independently associated with increased odds of death (OR = 3.09, 95% CI: 2.66-3.59) and the composite outcome (OR = 1.62, 95% CI: 1.53-1.71). Hematologic and autoimmune comorbidities also conferred increased risk.
conclusionCKD significantly worsens clinical outcomes in dengue fever. These findings highlight the need for early recognition, tailored care, and targeted public health strategies to protect this high-risk population during dengue outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.